Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Exemestane Tablets

Approval Number

国药准字HJ20160052

CompanyPfizer Italia S.R.L.

Registration Date

September 4, 2020

Previous Approval Numbers

H20160052

Drug Information

Generic Name

依西美坦片

Trade Name

阿诺新

Brand Name

阿诺新

Dosage Form

片剂

Strength

25mg

Drug Type

化学药品

Registration Date

September 4, 2020

Expiry Date

September 3, 2025

Company Information

Applicant Company

Company NamePfizer Italia S.R.L.

Company Address

Via Isonzo, 71-04100 Latina,Italy

Manufacturing Company

Company NamePfizer Italia S.R.L.

Company Address

Localita Marino del Tronto 63100(AP),Italy

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy